Monday, September 22, 2025

11:00 AM - 12:30 PM

Grand Copthorne Waterfront Hotel - Waterfront Ballroom II

---

Details

Programmatic treatment is the corner stone of TB treatment as it provides evidence treatment feasible in high burdened settings. Despite the success of programmatic treatment, patients experience significant side effects, slow response to treatment, or acquire drug resistance. This session will provide latest insight in relationship between drug dose – exposure and effect, will identify patients who are at risk for suboptimal treatment, present technology to measure drug concentrations without invasive blood collection, shows the challenges with new TB drugs and will discuss feasibility and challenges for adoption of TDM in TB programs.